2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide

C17H13F3N2O2 — CID 110768191

IUPAC2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide
SMILESO=C(Cc1ccc2c(c1)CC(=O)N2)Nc1ccc(C(F)(F)F)cc1
InChIInChI=1S/C17H13F3N2O2/c18-17(19,20)12-2-4-13(5-3-12)21-15(23)8-10-1-6-14-11(7-10)9-16(24)22-14/h1-7H,8-9H2,(H,21,23)(H,22,24)
InChIKeyFHDRJDQUXOAAPD-UHFFFAOYSA-N
MW334.30 g/mol
LogP3.38
Rot. Bonds3

About 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide

2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide (PubChem CID 110768191) has the molecular formula C17H13F3N2O2 and a molecular weight of 334.30 g/mol. Its IUPAC name is 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide.

Molecular Properties

Compound Name2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide
PubChem CID110768191
Molecular FormulaC17H13F3N2O2
Molecular Weight334.30 g/mol
Exact Mass334.09
IUPAC Name2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide
SMILESO=C(Cc1ccc2c(c1)CC(=O)N2)Nc1ccc(C(F)(F)F)cc1
InChIInChI=1S/C17H13F3N2O2/c18-17(19,20)12-2-4-13(5-3-12)21-15(23)8-10-1-6-14-11(7-10)9-16(24)22-14/h1-7H,8-9H2,(H,21,23)(H,22,24)
InChIKeyFHDRJDQUXOAAPD-UHFFFAOYSA-N
XLogP3.38
TPSA58.20 Ų
H-Bond Donors2
H-Bond Acceptors2
Rotatable Bonds3
Heavy Atoms24
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500334.30
LogP ≤ 53.38
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 102

Analyze 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(2-oxo-3,4-dihydro-1H-quinolin-6-yl)-N-[3-(trifluoromethyl)phenyl]acetamide
CID 110768501
2-(2-oxo-1,3-dihydroindol-5-yl)-N-(2,3,4-trifluorophenyl)acetamide
CID 110768234
2-(2-oxo-1,3-dihydroindol-5-yl)-N-prop-2-enylacetamide
CID 110768065
2-(2-fluorophenyl)-N-(2-oxo-1,3-dihydroindol-5-yl)acetamide
CID 110777106
N'-methyl-2-(2-oxo-1,3-dihydroindol-5-yl)acetohydrazide
CID 116846191
2-(2-oxo-1,3-dihydroindol-5-yl)acetamide
CID 82490915
4-oxo-4-(2-oxo-1,3-dihydroindol-5-yl)-N-[3-(trifluoromethyl)phenyl]butanamide
CID 110344893
2-(1,3-benzodioxol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide
CID 110860892
N-[2-(4-fluorophenyl)ethyl]-2-(2-oxo-1,3-dihydroindol-5-yl)acetamide
CID 110768108
2-(4-hydroxyphenyl)-N-[4-(trifluoromethyl)phenyl]acetamide
CID 14879849
N-(4-acetamidophenyl)-2-[4-(trifluoromethyl)phenyl]acetamide
CID 51271866
N-[4-[2-(dimethylamino)ethyl]phenyl]-2-(2-oxo-1,3-dihydroindol-6-yl)acetamide
CID 136529868

Frequently Asked Questions

What is the IUPAC name of 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide?
The IUPAC name of 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide (CID 110768191) is 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide.
What is the SMILES notation for 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide?
The canonical SMILES for 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide is O=C(Cc1ccc2c(c1)CC(=O)N2)Nc1ccc(C(F)(F)F)cc1.
What is the InChIKey of 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide?
The InChIKey is FHDRJDQUXOAAPD-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H13F3N2O2/c18-17(19,20)12-2-4-13(5-3-12)21-15(23)8-10-1-6-14-11(7-10)9-16(24)22-14/h1-7H,8-9H2,(H,21,23)(H,22,24).
What are the key properties of 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide?
2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide has a molecular weight of 334.30 g/mol, XLogP of 3.38, 3 rotatable bonds, 2 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2-oxo-1,3-dihydroindol-5-yl)-N-[4-(trifluoromethyl)phenyl]acetamide is sourced from PubChem (CID 110768191), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).